Capital Research Global Investors Bristol Myers Squibb CO Transaction History
Capital Research Global Investors
- $463 Billion
- Q3 2024
A detailed history of Capital Research Global Investors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capital Research Global Investors holds 1,150,000 shares of BMY stock, worth $67.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,150,000
Previous 1,341,776
14.29%
Holding current value
$67.8 Million
Previous $55.7 Million
6.8%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding BMY
# of Institutions
2,602Shares Held
1.46BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$11.1 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.35 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.48 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.59 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.6 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $125B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...